Unexpected toxicity in patients treated with iphosphamide.
D058186:Acute Kidney Injury / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000633:toxicity*; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003498:Cyclic P-Oxides / Q000008:administration & dosage / Q000633:toxicity; D003520:Cyclophosphamide; D005021:Ethylamines / Q000008:administration & dosage / Q000633:toxicity; D005260:Female; D006417:Hematuria / Q000139:chemically induced; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006869:Hydronephrosis / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D009325:Nausea / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010078:Oxazines / Q000008:administration & dosage / Q000633:toxicity*; D011704:Pyelonephritis / Q000139:chemically induced; D012512:Sarcoma, Ewing / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced; D014511:Uremia / Q000139:chemically induced; D014555:Urination Disorders / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D003498:Cyclic P-Oxides; D005021:Ethylamines; D006454:Hemoglobins; D010078:Oxazines; D003520:Cyclophosphamide